GlassScriptPhysician profile
Mohammed S Alo
NPI 1447499462
$6,736.08
in general payments reported to CMS, 2019-2025
40 companies · $250 in 2025
The $250 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,448 · 2020: $750 · 2021: $1,202 · 2022: $1,193 · 2023: $1,365 · 2024: $529 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,059 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,059.09 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $734.19 | 2023-2024 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $682.52 | 2019-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $634.10 | 2019-2024 | Farxiga, Wainua |
| Novartis Pharmaceuticals Corporation | $624.44 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $577.42 | 2019-2024 | Jardiance |
| Amgen INC. | $500.17 | 2019-2024 | Repatha |
| Pfizer INC. | $400.19 | 2019-2023 | |
| Esperion Therapeutics, INC. | $382.26 | 2021-2022 | |
| Amarin Pharma, INC. | $308.58 | 2019-2021 | |
| Atricure, INC. | $246.12 | 2019-2025 | Synergy Ablation System |
| Actelion Pharmaceuticals US, INC. | $229.56 | 2023-2025 | Opsumit, Uptravi |
| Sanofi-Aventis U.S. LLC | $117.82 | 2019 | |
| Boston Scientific Corporation | $116.91 | 2023 | Watchman Access System, Watchman Flx |
| Merck Sharp & Dohme LLC | $112.28 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $104.11 | 2019 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Alo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.